- Home
- PSF vs DRTS Comparison
PSF vs DRTS Comparison
Compare PSF & DRTS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PSF
- DRTS
- Stock Information
- Founded
- PSF 2010
- DRTS 2015
- Country
- PSF United States
- DRTS Israel
- Employees
- PSF N/A
- DRTS N/A
- Industry
- PSF Investment Managers
- DRTS Medical/Dental Instruments
- Sector
- PSF Finance
- DRTS Health Care
- Exchange
- PSF Nasdaq
- DRTS Nasdaq
- Market Cap
- PSF 227.2M
- DRTS 211.7M
- IPO Year
- PSF N/A
- DRTS N/A
- Fundamental
- Price
- PSF $19.50
- DRTS $2.95
- Analyst Decision
- PSF
- DRTS Strong Buy
- Analyst Count
- PSF 0
- DRTS 2
- Target Price
- PSF N/A
- DRTS $8.00
- AVG Volume (30 Days)
- PSF 25.0K
- DRTS 29.8K
- Earning Date
- PSF 01-01-0001
- DRTS 05-19-2025
- Dividend Yield
- PSF 7.69%
- DRTS N/A
- EPS Growth
- PSF N/A
- DRTS N/A
- EPS
- PSF N/A
- DRTS N/A
- Revenue
- PSF N/A
- DRTS N/A
- Revenue This Year
- PSF N/A
- DRTS N/A
- Revenue Next Year
- PSF N/A
- DRTS N/A
- P/E Ratio
- PSF N/A
- DRTS N/A
- Revenue Growth
- PSF N/A
- DRTS N/A
- 52 Week Low
- PSF $16.00
- DRTS $1.75
- 52 Week High
- PSF $20.19
- DRTS $4.39
- Technical
- Relative Strength Index (RSI)
- PSF 56.55
- DRTS 68.40
- Support Level
- PSF $19.04
- DRTS $2.50
- Resistance Level
- PSF $19.50
- DRTS $2.96
- Average True Range (ATR)
- PSF 0.21
- DRTS 0.15
- MACD
- PSF 0.06
- DRTS 0.04
- Stochastic Oscillator
- PSF 100.00
- DRTS 97.83
About PSF Cohen & Steers Select Preferred and Income Fund Inc.
Cohen & Steers Select Preferred and Income Fund Inc is a diversified, closed-end investment company. The Fund's primary investment objective is high current income with capital appreciation as its secondary objective. The Fund invests at least of its Managed Assets in preferred and other income securities issued by U.S. and non-U.S. companies.
About DRTS Alpha Tau Medical Ltd.
Alpha Tau Medical Ltd is a clinical-stage oncology therapeutics company focused on harnessing the innate relative biological effectiveness and short range of alpha particles for use as localized radiation therapy for solid tumors. The Alpha CaRT technology of the company utilizes the therapeutic properties of alpha particles aiming to overcome, and harness for benefit for alpha radiation's range. The company derives maximum revenue from Israel.